Ranitidine Dosing in Children
For pediatric patients requiring ranitidine, the recommended dose is 1 mg/kg per dose (range 12.5-50 mg, maximum 50 mg per dose) for intramuscular or intravenous administration in acute settings like anaphylaxis, or 2-4 mg/kg per dose orally every 12 hours for gastrointestinal indications. 1, 2
Context-Specific Dosing Recommendations
For Anaphylaxis (Acute Parenteral Administration)
- Administer 1 mg/kg per dose (12.5-50 mg range, maximum 50 mg) intramuscularly or intravenously 1, 2
- For IV administration, dilute in 5% dextrose to a total volume of 20 mL and inject over 5 minutes 1
- Critical caveat: Ranitidine is second-line therapy to epinephrine and should NEVER be administered alone in anaphylaxis 1, 2
- Combination of diphenhydramine plus ranitidine is superior to diphenhydramine alone 1, 2
For Gastrointestinal Indications (Oral Administration)
Standard dosing:
- Oral: 2-4 mg/kg per dose every 12 hours (based on indication severity) 3, 4
- Maximum single dose: 150 mg 5
Evidence-based dosing considerations:
- For mild GERD symptoms: 75 mg fixed dose (approximately 1.5-2.7 mg/kg in children 4-11 years) provides 5-6 hours of acid suppression 6
- For sustained acid suppression beyond 6 hours: Doses ≥3 mg/kg per dose are required 4
- Low doses (<3 mg/kg) maintained gastric pH >4 for only 29% of time during hours 4-6 post-dose
- High doses (≥3 mg/kg) maintained gastric pH >4 for 89% of time during hours 4-6 post-dose 4
For Critically Ill Children (Stress Ulcer Prophylaxis)
Intravenous administration:
- 1.5 mg/kg IV every 6 hours is most effective for maintaining gastric pH ≥4 3
- This regimen achieved pH ≥4 for >80% of the study period in 80% of patients
- Alternative: 4 mg/kg/day total dose (1 mg/kg every 6 hours or continuous infusion) 7
Continuous infusion option:
- 0.15 mg/kg bolus followed by 0.15 mg/kg/hour continuous infusion 7
- Both bolus and continuous infusion regimens at 4 mg/kg/day total are equally effective 7
For Neonates
Special population considerations:
- Initial dose: 2 mg/kg IV over 10 minutes 8
- Maintenance: 2 mg/kg/24 hours as continuous infusion maintains gastric pH >4 in >90% of patients 8
- Neonates have significantly prolonged elimination half-life (6.61 hours vs. 2-3 hours in older children) 8
- Dosing frequency should not exceed every 12 hours in term neonates with stable renal/hepatic function 8
- Plasma clearance in neonates <1 month is considerably lower (3 mL/min/kg) than in older children or adults 5
Important Clinical Considerations
Bioavailability and Absorption
- Oral bioavailability is approximately 48-50% in children, comparable to adults 5
- Peak levels occur 2-3 hours after oral dosing 5, 6
- Food and antacids do not significantly impair absorption 5
Renal Dosing Adjustments
- Ranitidine is primarily renally eliminated (30% unchanged in urine) 5
- In patients with creatinine clearance 25-35 mL/min, elimination half-life increases to 4.8 hours 5
- Dose reduction required in proportion to creatinine clearance reduction 5
Common Pitfalls to Avoid
- Never use ranitidine as monotherapy for anaphylaxis - it is adjunctive only to epinephrine 1, 2
- Avoid underdosing for sustained acid suppression - doses <3 mg/kg provide inadequate duration of effect beyond 4-6 hours 4
- Do not use adult dosing in neonates - significantly reduced clearance requires lower doses and longer intervals 5, 8
- Monitor gastric pH when possible - individual response varies and dose adjustment may be needed 8, 7
Route-Specific Summary
| Route | Indication | Dose | Frequency |
|---|---|---|---|
| IM/IV | Anaphylaxis | 1 mg/kg (max 50 mg) | As needed [1,2] |
| IV | Critically ill children | 1.5 mg/kg | Every 6 hours [3] |
| IV continuous | Neonates/ECMO | 2 mg/kg/24h | Continuous [8] |
| Oral | GERD (standard) | 2-4 mg/kg | Every 12 hours [3,4] |
| Oral | GERD (sustained) | ≥3 mg/kg (max 150 mg) | Every 12 hours [4] |